- Report
- March 2025
- 200 Pages
Global
From €4074EUR$4,490USD£3,491GBP
- Report
- January 2025
- 165 Pages
Global
From €2586EUR$2,850USD£2,216GBP
- Report
- April 2025
- 82 Pages
Global
From €5308EUR$5,850USD£4,548GBP
- Report
- December 2024
- 150 Pages
Global
From €3403EUR$3,750USD£2,915GBP
- Report
- December 2024
- 200 Pages
Global
From €3403EUR$3,750USD£2,915GBP
- Book
- December 2020
- 400 Pages
From €150EUR$165USD£128GBP
- Book
- April 2023
- 688 Pages
- Book
- September 2022
- 480 Pages
- Book
- July 2022
- 880 Pages
- Book
- December 2019
- 432 Pages
- Book
- December 2019
- 432 Pages
- Book
- January 2018
- 144 Pages
- Book
- February 2016
- 448 Pages
- Book
- March 2015
- 512 Pages

Acute Coronary Syndrome (ACS) is a term used to describe a range of conditions that occur when the blood supply to the heart is suddenly blocked. It is a major cause of death and disability worldwide, and is the most common type of heart attack. ACS is a medical emergency and requires immediate medical attention. Symptoms of ACS include chest pain, shortness of breath, nausea, and sweating. Treatment for ACS includes medications, lifestyle changes, and in some cases, surgery.
The ACS market is a rapidly growing segment of the cardiology industry. It is driven by the increasing prevalence of cardiovascular diseases, the development of new treatments, and the growing demand for better patient care. Companies in the ACS market include Abbott, Boston Scientific, Medtronic, and St. Jude Medical. Show Less Read more